Quantifizierung von CMV-DNA als diagnostisches Werkzeug zur verbesserten Behandlung und berwachung von Risikopatienten/CMV Genome Quantification as a Diagnostic Tool for Improving Treatment and Monitoring of Risk Patients

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Unknown venue

• Publication date

  2002-10-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1515/LabMed.2002.058
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation.

  2002cited by this paper
• Performance characteristics of an automated PCR assay for the quantification of cytomegalovirus DNA in plasma.

  2002cited by this paper
• Viral genome quantification as a tool for improving patient management: the example of HIV, HBV, HCV and CMV.

  2002cited by this paper
• Real-time PCR in virology.

  2002cited by this paper
• Definitions of cytomegalovirus infection and disease in transplant recipients.

  2002cited by this paper
• Real-Time PCR Quantification of Human Cytomegalovirus DNA in Amniotic Fluid Samples from Mothers with Primary Infection

  2002cited by this paper
• Development and evaluation of an internally controlled semiautomated PCR assay for quantification of cell‐free cytomegalovirus

  2002cited by this paper
• A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.

  2002cited by this paper
• Role of the Laboratory in Diagnosis and Management of Cytomegalovirus Infection in Hematopoietic Stem Cell and Solid-Organ Transplant Recipients

  2002cited by this paper
• Quantifizierung von CMV‐DNA als diagnostischesWerkzeug zur verbesserten Behandlung und Überwachungvon Risikopatienten

  2002cited by this paper
• Progress in understanding cytomegalovirus drug resistance.

  2001cited by this paper
• Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants.

  2001cited by this paper
• Diagnosis and prognostic markers of HCMV infection.

  2001cited by this paper
• Comparison of Quantitative and Qualitative PCR Assays for Cytomegalovirus DNA in Plasma

  2001cited by this paper
• Validation and standardisation of nucleic acid amplification technology (NAT) assays for the detection of viral contamination of blood and blood products.

  2001cited by this paper
• Quantitation of viral load using real-time amplification techniques.

  2001cited by this paper
• Investigation of CMV disease in immunocompromised patients

  2001cited by this paper
• Quantitative Analysis of Cytomegalovirus (CMV) Viremia Using the pp65 Antigenemia Assay and the COBAS AMPLICOR CMV MONITOR PCR Test after Blood and Marrow Allogeneic Transplantation

  2000cited by this paper
• Extended routine polymerase chain reaction surveillance and pre‐emptive antiviral therapy for cytomegalovirus after allogeneic transplantation

  2000cited by this paper
• Quantitative molecular virology in patient management

  2000cited by this paper
• Comparison of Quantitative Cytomegalovirus (CMV) PCR in Plasma and CMV Antigenemia Assay: Clinical Utility of the Prototype AMPLICOR CMV MONITOR Test in Transplant Recipients

  2000cited by this paper
• Viral Dynamics during Active Cytomegalovirus Infection and Pathology

  2000cited by this paper
• Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns.

  1999cited by this paper
• Evaluation of New Quantitative Assays for Diagnosis and Monitoring of Cytomegalovirus Disease in Human Immunodeficiency Virus-Positive Patients

  1999cited by this paper
• Summary of the II International Symposium on Cytomegalovirus.

  1998cited by this paper
• Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients.

  1998cited by this paper
• Quantitation of Cytomegalovirus: Methodologic Aspects and Clinical Applications

  1998cited by this paper
• Summary of the international consensus symposium on management of HIV, CMV and hepatitis virus infections.

  1998cited by this paper
• Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.

  1998cited by this paper
• New PCR assay for rapid and quantitative detection of human cytomegalovirus in cerebrospinal fluid

  1996cited by this paper
• Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease.

  1995cited by this paper
• Low correlation of human cytomegalovirus DNA amplification by polymerase chain reaction with cytomegalovirus disease in organ transplant recipients

  1994cited by this paper
• Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow Transplant

  1993cited by this paper
• Ganciclovir Prophylaxis of Cytomegalovirus Infection and Disease in Allogeneic Bone Marrow Transplant Recipients: Results of a Placebo-Controlled, Double-Blind Trial

  1993cited by this paper

• No citing papers are available for this paper.